Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big B…
| Periodo | 2026-12 | 2026-08 | 2026-02 | 2025-12 |
|---|---|---|---|---|
| Real | — | — | $-0.01 | $-0.20 |
| Estimado | $0.01 | $-0.01 | $-0.01 | $-0.01 |
| Sorpresa | — | — | +0.0% | -1900.0% |
| Métrica | OGI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 29.7% | 57.4% | -27.7% |
| Operating Margin | -22.3% | -34.4% | +12.1% |
| Net Margin | -28.4% | -32.5% | +4.0% |
| FCF Margin | -0.5% | -12.6% | +12.1% |
| ROE | -14.8% | -39.2% | +24.3% |
| ROA | -11.1% | -30.9% | +19.8% |
| Current Ratio | 4.92 | 2.73 | +2.19 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |
| Tendencia (Piotroski) | FY24 | FY23 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -11.1% | — |
| ✓Flujo de caja operativo positivo | CA$4M | −CA$39M |
| ✓Rentabilidad sobre activos al alza | -11.1% | -83.3% |
| ✓Caja operativa/activos supera al ROA | 0.9% | ROA -11.1% |
| ✓Menos deuda a largo plazo | 0.0% | 0.0% |
| ✗Mejor liquidez (ratio corriente) | 4.92 | 6.95 |
| ✗Sin aumentar el nº de acciones | 95M | 81M |
| ✓Margen bruto al alza | 29.7% | 23.5% |
| ✗Rotación de activos al alza | 0.39 | 0.54 |
| Calidad del negocio | FY24 |
|---|---|
| ✗Margen FCF > 10 % | -0.5% |
| ✗ROCE > 10 % | -10.1% |
| ✓Ventas > 5 %/año (3 años) | 26.4% |
| ✓Deuda neta/EBITDA < 3x | 0.0x |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 10.0% |
ORGANIGRAM GLOBAL INC. cotiza a 0.93 USD y tiene una capitalización bursátil de $134M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud